Literature DB >> 3053160

Purification of a NF1-like DNA-binding protein from rat liver and cloning of the corresponding cDNA.

G Paonessa1, F Gounari, R Frank, R Cortese.   

Abstract

NF1-like proteins play a role in transcription of liver-specific genes. A DNA-binding protein, recognizing half of the canonical NF1 binding site (TGGCA) present on the human albumin and retinol-binding protein genes, has been purified from rat liver. Several peptides deriving from a tryptic digest of the purified protein were sequenced and the sequence was used to synthesize specific oligonucleotides. Two overlapping cDNA clones were obtained from a rat-liver cDNA library; their sequence reveals an open reading frame coding for 505 amino acids, including all the peptides sequenced from the purified protein. The DNA-binding domain, most likely located within the first 250 amino acids, is highly homologous to the sequence of CTF/NF1 purified from HeLa cells. Northern analysis reveals several mRNA species present in different combinations in various rat tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053160      PMCID: PMC454701          DOI: 10.1002/j.1460-2075.1988.tb03178.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  57 in total

1.  Immunoglobulin gene transcription is activated by downstream sequence elements.

Authors:  C Queen; D Baltimore
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

2.  Cell-specific expression controlled by the 5'-flanking region of insulin and chymotrypsin genes.

Authors:  M D Walker; T Edlund; A M Boulet; W J Rutter
Journal:  Nature       Date:  1983 Dec 8-14       Impact factor: 49.962

3.  The TGGCA-binding protein: a eukaryotic nuclear protein recognizing a symmetrical sequence on double-stranded linear DNA.

Authors:  U Borgmeyer; J Nowock; A E Sippel
Journal:  Nucleic Acids Res       Date:  1984-05-25       Impact factor: 16.971

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations.

Authors:  R Lathe
Journal:  J Mol Biol       Date:  1985-05-05       Impact factor: 5.469

6.  Cell-specific expression of a transfected human alpha 1-antitrypsin gene.

Authors:  G Ciliberto; L Dente; R Cortese
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

7.  Two distinct factors interact with the promoter regions of several liver-specific genes.

Authors:  E M Hardon; M Frain; G Paonessa; R Cortese
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

8.  Recognition site of nuclear factor I, a sequence-specific DNA-binding protein from HeLa cells that stimulates adenovirus DNA replication.

Authors:  P A Leegwater; W van Driel; P C van der Vliet
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

9.  Tissue-specific expression is conferred by a sequence from the 5' end of the rat albumin gene.

Authors:  M O Ott; L Sperling; P Herbomel; M Yaniv; M C Weiss
Journal:  EMBO J       Date:  1984-11       Impact factor: 11.598

10.  A human hepatitis B viral enhancer element.

Authors:  Y Shaul; W J Rutter; O Laub
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

View more
  86 in total

1.  Expression, DNA-binding specificity and transcriptional regulation of nuclear factor 1 family proteins from rat.

Authors:  S Osada; T Matsubara; S Daimon; Y Terazu; M Xu; T Nishihara; M Imagawa
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

2.  Downregulation of constitutive and heavy metal-induced metallothionein-I expression by nuclear factor I.

Authors:  S Majumder; K Ghoshal; R M Gronostajski; S T Jacob
Journal:  Gene Expr       Date:  2001

3.  Characterization of an enhancer upstream from the muscle-type promoter of a gene encoding 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Authors:  M I Darville; I V Antoine; G G Rousseau
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

4.  Transcription factors NFI and NFIII/oct-1 function independently, employing different mechanisms to enhance adenovirus DNA replication.

Authors:  Y M Mul; C P Verrijzer; P C van der Vliet
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

5.  The transcription factor LF-A1 interacts with a bipartite recognition sequence in the promoter regions of several liver-specific genes.

Authors:  D P Ramji; M H Tadros; E M Hardon; R Cortese
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

6.  Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.

Authors:  S Ethelberg; B D Tzschaschel; A Luz; S J Diaz-Cano; F S Pedersen; J Schmidt
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Nuclear factor I is specifically targeted to discrete subnuclear sites in adenovirus type 2-infected cells.

Authors:  J Bosher; A Dawson; R T Hay
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

8.  Hydroxyl radical footprints reveal novel structural features around the NF I binding site in adenovirus DNA.

Authors:  H Zorbas; L Rogge; M Meisterernst; E L Winnacker
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

9.  The DNA sequence encompassing the transcription start site of a TATA-less promoter contains enough information to drive neuron-specific transcription.

Authors:  R Faraonio; G Minopoli; A Porcellini; F Costanzo; F Cimino; T Russo
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

10.  Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines.

Authors:  M Plumb; R Fulton; L Breimer; M Stewart; K Willison; J C Neil
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.